These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24854104)

  • 21. β-Carotene synergistically enhances the anti-tumor effect of 5-fluorouracil on esophageal squamous cell carcinoma in vivo and in vitro.
    Zhang Y; Zhu X; Huang T; Chen L; Liu Y; Li Q; Song J; Ma S; Zhang K; Yang B; Guan F
    Toxicol Lett; 2016 Nov; 261():49-58. PubMed ID: 27586268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
    Caro M; Font A; Comas S; Viciano M; Remon J; Céliz P; Robles J; Musulén E; Sendrós MJ; Mesalles E; Jiménez JA; Boix J; Arellano A; Fernández-Llamazares J
    Clin Transl Oncol; 2016 Nov; 18(11):1106-1113. PubMed ID: 26856597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel 5-fluorouracil-resistant human esophageal squamous cell carcinoma cell line Eca-109/5-FU with significant drug resistance-related characteristics.
    Zhang C; Ma Q; Shi Y; Li X; Wang M; Wang J; Ge J; Chen Z; Wang Z; Jiang H
    Oncol Rep; 2017 May; 37(5):2942-2954. PubMed ID: 28393186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive Binding Between Id1 and E2F1 to Cdc20 Regulates E2F1 Degradation and Thymidylate Synthase Expression to Promote Esophageal Cancer Chemoresistance.
    Li B; Xu WW; Guan XY; Qin YR; Law S; Lee NP; Chan KT; Tam PY; Li YY; Chan KW; Yuen HF; Tsao SW; He QY; Cheung AL
    Clin Cancer Res; 2016 Mar; 22(5):1243-55. PubMed ID: 26475334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway.
    Ono H; Sowa Y; Horinaka M; Iizumi Y; Watanabe M; Morita M; Nishimoto E; Taguchi T; Sakai T
    Breast Cancer Res Treat; 2018 Aug; 171(1):43-52. PubMed ID: 29752686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of thymidilate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or raltitrexed.
    Di Gennaro E; Bruzzese F; Pepe S; Leone A; Delrio P; Subbarayan PR; Avallone A; Budillon A
    Cancer Biol Ther; 2009 May; 8(9):782-91. PubMed ID: 19270508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma.
    Shoji M; Ninomiya I; Makino I; Kinoshita J; Nakamura K; Oyama K; Nakagawara H; Fujita H; Tajima H; Takamura H; Kitagawa H; Fushida S; Harada S; Fujimura T; Ohta T
    Int J Oncol; 2012 Jun; 40(6):2140-6. PubMed ID: 22469995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
    Hsueh CT; Kelsen D; Schwartz GK
    Clin Cancer Res; 1998 Sep; 4(9):2201-6. PubMed ID: 9748140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy alone and in combination with bleomycin and 5-fluorouracil in advanced carcinoma esophagus.
    Hukku S; Fernandes P; Vasishta S; Sharma VK
    Indian J Cancer; 1989 Sep; 26(3):131-6. PubMed ID: 2483556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.
    Kim MJ; Choi SK; Hong SH; Eun JW; Nam SW; Han JW; You JS
    Int J Oncol; 2018 Jul; 53(1):395-403. PubMed ID: 29749437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of interferon-beta in combination with 5-fluorouracil on the growth of esophageal cancer cells in vitro.
    Tsunoo H; Komura S; Ohishi N; Akiyama S; Kasai Y; Ito K; Nakao A; Yagi K
    Anticancer Res; 2001; 21(5):3301-6. PubMed ID: 11848487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T; Fuwa N; Kamata M; Furutani K; Tachibana H; Yamazaki T
    Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
    Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
    Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells.
    Ji N; Jiang L; Deng P; Xu H; Chen F; Liu J; Li J; Liao G; Zeng X; Lin Y; Feng M; Li L; Chen Q
    J Oral Pathol Med; 2017 Mar; 46(3):201-207. PubMed ID: 27465776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin potentiates the antitumor effects of 5-FU in treatment of esophageal squamous carcinoma cells through downregulating the activation of NF-κB signaling pathway in vitro and in vivo.
    Tian F; Fan T; Zhang Y; Jiang Y; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):847-55. PubMed ID: 23017833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of nedaplatin, 5-FU, and leucovorin combined with radiation therapy in unresectable esophageal carcinoma].
    Futami R; Tajiri T; Miyashita M; Maruyama H; Makino H; Nomura T; Tateno A; Miyashita T; Sasajima K
    Gan To Kagaku Ryoho; 2003 May; 30(5):681-4. PubMed ID: 12795101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303).
    Shinoda M; Ando N; Kato K; Ishikura S; Kato H; Tsubosa Y; Minashi K; Okabe H; Kimura Y; Kawano T; Kosugi S; Toh Y; Nakamura K; Fukuda H;
    Cancer Sci; 2015 Apr; 106(4):407-12. PubMed ID: 25640628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The combined radio-chemotherapy of inoperable esophageal cancer].
    Köhler AH
    Radiobiol Radiother (Berl); 1990; 31(6):497-502. PubMed ID: 1714081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.